Get startedLog in
    Picture of Tessera Defense and Homeland Security logo

    HLSQ — Tessera Defense and Homeland Security News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Biomx To Present Preclinical Results With Bx004 In Cystic Fibrosis At The 44Th European Cystic Fibrosis Conference

    Picture of Tessera Defense and Homeland Security logoTessera Defense and Homeland Security
    09/06/2021 11:57
    June 9 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX TO PRESENT PRECLINICAL RESULTS WITH BX004 IN CYSTIC
FIBROSIS AT THE 44TH EUROPEAN CYSTIC FIBROSIS CONFERENCE
    * BIOMX INC - LOOK FORWARD TO ADVANCING BX004 TO A PHASE
1B/2A
TRIAL WITH RESULTS FROM PART 1 EXPECTED IN Q1 OF 2022

Source text for Eikon:  ID:nBw23ZY3Ba 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Tessera Defense and Homeland Security

    See all news